Fairvalue-Calculator Fairvalue-Calculator
EN DE

Zhejiang Gongdong Medical Technology Co (605369) Fair Value & Analysis

Healthcare · CN · Market cap 3.6B CNY

Price¥15.40
Fair Value¥7.87
Upside-48.9%
Quality94/100
Evidence: High Range ¥5.87 – ¥9.87

Analysis

Zhejiang Gongdong Medical Technology Co (605369) currently trades at ¥15.40, while our model-based Fair Value estimate is ¥7.87 — implying the stock looks roughly 48.9% overvalued today. We read business quality at 94/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Zhejiang Gongdong Medical Technology Co., Ltd. researches, develops, produces, and sells disposable medical consumables in China. Its products include blood collection tubes, needles and needle holders, and sharp containers; cell culture dishes, plates, bottles, flasks, and serological pipette solutions; laboratory consumables, such as petri dishes, centrifuge and cryo tubes, pipette tips, transfer pipettes, cuvettes, and test tubes; urine, stool, and sputum specimen collection containers; epidemic prevention products; vaginal, ear, and anus speculums, and sponge forceps nursing plasticwares; 95kpa specimen container customized solutions; and pharmaceutical packaging products. Zhejiang Gongdong Medical Technology Co., Ltd. was founded in 1985 and is based in Taizhou, China.

Open the full interactive analysis →

Similar stocks

Intuitive Surgical, Inc (ISRG) -61% EssilorLuxottica Société anonyme (ESLOF) -34% HOYA Corporation (HOCPY) -38% Medline Inc (MDLN) -5% Becton, Dickinson and Company (BDX) -16% Alcon Inc (ALC) -44%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.